p53-a Jack of all trades but master of none

被引:248
作者
Junttila, Melissa R.
Evan, Gerard I. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
关键词
ARF TUMOR-SUPPRESSOR; MYC-INDUCED APOPTOSIS; DNA-DAMAGE RESPONSE; IN-VIVO; EMBRYONIC LETHALITY; GENETIC INSTABILITY; MDM2-DEFICIENT MICE; INDUCED SENESCENCE; MUTANT MICE; MDM2;
D O I
10.1038/nrc2728
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancers are rare because their evolution is actively restrained by a range of tumour suppressors. Of these p53 seems unusually crucial as either it or its attendant upstream or downstream pathways are inactivated in virtually all cancers. p53 is an evolutionarily ancient coordinator of metazoan stress responses. Its role in tumour suppression is likely to be a relatively recent adaptation, which is only necessary when large, long-lived organisms acquired the sufficient size and somatic regenerative capacity to necessitate specific mechanisms to reign in rogue proliferating cells. However, such evolutionary reappropriation of this venerable transcription factor entails compromises that restrict its efficacy as a tumour suppressor.
引用
收藏
页码:821 / 829
页数:9
相关论文
共 91 条
  • [1] Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis
    Alt, JR
    Greiner, TC
    Cleveland, JL
    Eischen, CM
    [J]. EMBO JOURNAL, 2003, 22 (06) : 1442 - 1450
  • [2] Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics
    Aslanian, A
    Iaquinta, PJ
    Verona, R
    Lees, JA
    [J]. GENES & DEVELOPMENT, 2004, 18 (12) : 1413 - 1422
  • [3] DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
    Bartkova, J
    Horejsi, Z
    Koed, K
    Krämer, A
    Tort, F
    Zieger, K
    Guldberg, P
    Sehested, M
    Nesland, JM
    Lukas, C
    Orntoft, T
    Lukas, J
    Bartek, J
    [J]. NATURE, 2005, 434 (7035) : 864 - 870
  • [4] Mdm2, but not Mdm4, protects terminally differentiated smooth muscle cells from p53-mediated caspase-3-independent cell death
    Boesten, L. S. M.
    Zadelaar, S. M.
    De Clercq, S.
    Francoz, S.
    van Nieuwkoop, A.
    Biessen, E. A. L.
    Hofmann, F.
    Feil, S.
    Feil, R.
    Jochemsen, A. G.
    Zurcher, C.
    Havekes, L. M.
    van Vlijmen, B. J. M.
    Marine, J. -C
    [J]. CELL DEATH AND DIFFERENTIATION, 2006, 13 (12) : 2089 - 2098
  • [5] Multiple centrosomes arise from tetraploidy checkpoint failure and mitotic centrosome clusters in p53 and RB pocket protein-compromised cells
    Borel, F
    Lohez, OD
    Lacroix, FB
    Margolis, RL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) : 9819 - 9824
  • [6] Brodsky MH, 2000, GENE DEV, V14, P666
  • [7] INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence
    Brookes, S
    Rowe, J
    Ruas, M
    Llanos, S
    Clark, PA
    Lomax, M
    James, MC
    Vatcheva, R
    Bates, S
    Vousden, KH
    Parry, D
    Gruis, N
    Smit, N
    Bergman, W
    Peters, G
    [J]. EMBO JOURNAL, 2002, 21 (12) : 2936 - 2945
  • [8] Cancer and ageing: Rival demons?
    Campisi, J
    [J]. NATURE REVIEWS CANCER, 2003, 3 (05) : 339 - 349
  • [9] The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
    Christophorou, M. A.
    Ringshausen, I.
    Finch, A. J.
    Swigart, L. Brown
    Evan, G. I.
    [J]. NATURE, 2006, 443 (7108) : 214 - 217
  • [10] ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53
    Courtois, S
    Verhaegh, G
    North, S
    Luciani, MG
    Lassus, P
    Hibner, U
    Oren, M
    Hainaut, P
    [J]. ONCOGENE, 2002, 21 (44) : 6722 - 6728